---
category: news
title: "Lantheus and Progenics Reschedule Their Respective Special Meetings of Stockholders for Proposed Merger"
excerpt: "About Progenics Progenics is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find ... who require systemic anticancer therapy; and oral and subcutaneous formulations ..."
publishedDateTime: 2020-04-02T12:30:00Z
webUrl: "https://www.businesswire.com/news/home/20200402005433/en/Lantheus-Progenics-Reschedule-Respective-Special-Meetings-Stockholders"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "to53z8/YO4Itj5rKtXaFC7FPGcQmfU3ZWJwKqccrHw4cXaoF6TO+XoWobCkcymwFIA7ijtHqX6KpB5nzo2uA95PTOntcrqRf7uxVon6zsXUXgSmzqa2CW981XRAhGDymz94wdUqGDnsi63vrBdyas2CESmtUm2uRc5TI3J5nxOomcFQOhwQu6GHbam+nqIrxiTNu8jtKH/gafzT1didZqsf/fy/Wc16d6NJWZqZkTiU2UMdMMExhOZUiVhTSf7xOcbXd0L0CQ+Tc7FW6nAaVS3LyjY7YNwNSEf7DjzR65qiHwnawP5vGEWzarpvCvOF9;VAC8h/pZ3bqV9Oqf4t4mDQ=="
---

